AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Learn the best strategies for using credit card points when shopping online to maximize your savings.
18,914 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
IWM holders confront higher annual fees and a recurring reconstitution drag that can erode returns. Cheaper small-cap...
U.S. oil refiners are set for a historic profit surge as supply disruptions and stronger demand push refining margins...
A wave of headlines around massive news PayPal stock has investors scanning the market for clues. This article breaks...
Over the last year, small-cap index funds have posted surprisingly strong returns. This article explains why that hap...
When healthcare stocks rally, two ETFs often surface as popular bets: Vanguard Health Care (VHT) and Invesco Pharmace...
Machi Big Brother’s high-stakes run appears to be nearing an end as his Hyperliquid balance drops below $1 million. T...
A new frontier is waking up: autonomous AI agents powered by crypto. This morning minute reveals how on-chain incenti...
Bruno Mars is back with a new solo project, and the tracklist drop isn’t just music news—it’s a case study in modern ...
Bitcoin faces a sharp deleveraging as more than $370 million in liquidations hit long bets, while corporate buyers mo...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
Long-term savers are turning to reliable income streams. Three dividend ETFs stand out for 2026, balancing yield, qua...